4 Top Dividend Stocks to Buy Now
If you’re looking for steady income, dividend stocks are a…
Sell
23
OLYMY Quote, Financials, Valuation and Earnings
Last price:
$14.53
Seasonality move
:
1.3%
Day range:
$14.09 - $15.23
52-week range:
$13.13 - $19.69
Dividend yield:
0.79%
P/E ratio:
63.90x
P/S ratio:
2.64x
P/B ratio:
3.35x
Volume:
77.5K
Avg. volume:
74.4K
1-year change:
-3.77%
Market cap:
$16.5B
Revenue:
$6.5B
EPS (TTM):
$0.23
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Olympus has -- downside to fair value with a price target of -- per share.
OLYMY vs. S&P 500
-
Over the past 5 trading days, Olympus has underperformed the S&P 500 by -0.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Olympus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Olympus has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Olympus reported revenues of $1.6B.
Earnings Growth
-
Olympus has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Olympus reported earnings per share of $0.20.
Enterprise value:
16.3B
EV / Invested capital:
--
Price / LTM sales:
2.64x
EV / EBIT:
36.99x
EV / Revenue:
2.49x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-105.71x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
20.99x
Gross Profit (TTM):
$4.4B
Return On Assets:
2.29%
Net Income Margin (TTM):
3.68%
Return On Equity:
4.7%
Return On Invested Capital:
3.21%
Operating Margin:
17.93%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $6.5B | $6.5B | $6.6B | $1.6B | $1.6B | |
| Gross Profit | -- | $4.4B | $4.4B | $1B | $1.1B | |
| Operating Income | -- | $714.8M | $422.1M | -$130.2M | $288.8M | |
| EBITDA | -- | $1.2B | $776.8M | -$13.2M | $295.1M | |
| Diluted EPS | -- | $1.70 | $0.23 | -$0.14 | $0.20 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.4B | $4.9B | $5.5B | $6.2B | $4.6B | |
| Total Assets | $10.2B | $10.6B | $10.3B | $10.8B | $9.6B | |
| Current Liabilities | $2.9B | $2.6B | $2.5B | $2.8B | $2.9B | |
| Total Liabilities | $7.1B | $6.6B | $5.8B | $5.3B | $4.6B | |
| Total Equity | $3.1B | $4B | $4.5B | $5.5B | $4.9B | |
| Total Debt | -- | -- | -- | $2.3B | $1.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.5B | $729.4M | $293.6M | $339.7M | $380.7M | |
| Cash From Investing | -- | -- | $2.5B | -$164M | -$156.4M | |
| Cash From Financing | -- | -- | -$1.9B | -$262.8M | -$282M | |
| Free Cash Flow | -- | $206.4M | -$154.3M | $165.5M | $243.3M | |
OLYMY
Sector
Market Cap
$16.5B
$47.5M
Price % of 52-Week High
73.79%
47.37%
Dividend Yield
0.79%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-3.78%
-34.04%
Beta (5-Year)
--
0.752
Dividend yield:
0.79%
Annualized payout:
$0.12
Payout ratio:
-2.97%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$14.83
200-day SMA
Sell
Level
$16.42
Bollinger Bands (100)
Sell
Level
15.67 - 18.63
Chaikin Money Flow
Sell
Level
-105.2K
20-day SMA
Sell
Level
$15.05
Relative Strength Index (RSI14)
Sell
Level
34.72
ADX Line
Sell
Level
25.55
Williams %R
Neutral
Level
-73.3333
50-day SMA
Sell
Level
$15.88
MACD (12, 26)
Sell
Level
-0.33
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
4.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.4417)
Buy
CA Score
(Annual)
Level (-0.2911)
Buy
Beneish M-Score
(Annual)
Level (-2.5461)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-1.3509)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
Stock Forecast FAQ
In the current month, OLYMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OLYMY average analyst price target in the past 3 months is --.
-
Where Will Olympus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Olympus share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Olympus?
Analysts are divided on their view about Olympus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Olympus is a Sell and believe this share price will rise from its current level to --.
-
What Is Olympus's Price Target?
The price target for Olympus over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OLYMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Olympus is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OLYMY?
You can purchase shares of Olympus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Olympus shares.
-
What Is The Olympus Share Price Today?
Olympus was last trading at $14.53 per share. This represents the most recent stock quote for Olympus. Yesterday, Olympus closed at $14.53 per share.
-
How To Buy Olympus Stock Online?
In order to purchase Olympus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Uber Stock Recover?
Shares of Uber Technologies (NYSE:UBER) have had a rough few…
Is ARK Next Generation Internet ETF a Good Investment?
The ARK Next Generation Internet ETF looks like a pretty…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 114x
Sell
39
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
87
CEG alert for Jan 11
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
1
MCY alert for Jan 11
Mercury General [MCY] is down 19.87% over the past day.
Buy
84
ATZAF alert for Jan 11
Aritzia [ATZAF] is up 17.63% over the past day.
